Drxver Tablet Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
ALBENDAZOLE-400MG
Uses:
Parasitic worm infections
Medicinal Benefits:
Drxver Tablet belongs to a group of medicines called anthelmintic used to treat worm infections such as neurocysticercosis (infection caused by pork tapeworm) and cystic hydatid disease (infection caused by dog tapeworm). Drxver Tablet is also used to treat infections caused by roundworms, hookworms, threadworms, whipworms, pinworms, flukes, and other parasites. Drxver Tablet is a broad-spectrum anthelmintic drug which is highly effective against a wide range of intestinal helminths, including cestodes, nematodes, and trematodes. It is also effective against tissue helminth infections like cutaneous larva migrans (parasitic skin infections). Drxver Tablet exhibits ovicidal, larvicidal and vermicidal activity. Drxver Tablet inhibits tubulin polymerisation, which causes metabolic disruption and energy depletion in the parasite. This leads to the immobilisation of the parasite. Thereby, Drxver Tablet kills the susceptible helminth and treats the infection.
Drxver Tablet causes metabolic disruption and energy depletion in the parasite, which leads to its immobilisation. Thereby, Drxver Tablet kills the susceptible helminth and treats the infection.
For neurocysticercosis, Drxver Tablet is usually prescribed for 8-30 days. For cystic hydatid disease, Drxver Tablet is usually prescribed for 28 days, followed by a 14 day break, and repeated for a total of 3 cycles.
Do not discontinue Drxver Tablet without consulting your doctor. To treat your condition effectually continue taking Drxver Tablet for as long as prescribed. Do not be reluctant to speak with your doctor if you feel any difficulty while taking Drxver Tablet.
You are recommended to avoid planning for pregnancy while taking Drxver Tablet as it may cause foetal harm. A pregnancy test should be done before starting the treatment with Drxver Tablet, and women must use effective birth-control while taking Drxver Tablet and for at least 1month after cessation of treatment.
Regular monitoring of blood count at the beginning of each cycle therapy and for every 2weeks while taking Drxver Tablet is advised for all patients. Treatment with Drxver Tablet should be discontinued if a significant decrease in blood cell count is observed.
Treatment with Drxver Tablet has been associated with mild to moderate elevations of liver enzymes. These elevations generally return to normal upon discontinuation of Drxver Tablet. Liver function tests should be performed before each treatment cycle and for every 2weeks during the treatment. Treatment with Drxver Tablet should be discontinued if the liver enzymes exceed twice the upper limit of normal.
Drxver Tablet might increase the chances of getting an infection. Maintain proper hygiene and try to stay away from people with infections, flu or cold.
You may bleed or bruise easily while taking Drxver Tablet. Be cautious while using sharp objects and try to avoid injuries. Consult your doctor if you notice unusual bleeding or bruising.